StockTipsArenaBeta

BUY CREDITACCESS GRAMEEN LIMITED — Emkay Global

BUYCREDITACCESS GRAMEEN LIMITED
CREDITACCESS GRAMEEN share price target & all analyst calls

byEmkay GlobalHorizon: NA (inferred 1 year)23 Oct 2026via Moneycontrol Broker Research

Entry₹1,027.4Inferred
Target₹1,500
Total upside +46.00%
Stop lossNot given
CMP₹1,030.3Just now
Active+0.28%+45.59%upside left 12 mo left
Follow Emkay Global for new calls(64% target hit, 378 closed calls)Get alertsWatch CREDITACC for new buy/sell callsGet alertsSee 23 other Long-term calls on CREDITACCSee 245 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 29 Oct, 11:45 am IST
17 supporting2 neutral0 opposing
Supports the BUY call (17)

Long-term trend bullish — 200-day average rising over the past quarter

Technicals · trend·28 Oct · yesterday

8 other SEBI-registered advisors have active long-term BUY calls on this stock, all issued in the last 14 days

Advisor consensus · same horizon·26 Oct · 3d ago

From Havells To Cyient Q2 Results Review: HDFC Securities Sees Up To 74% Upside; Check Target Prices

NewsNdtv-Profit·23 Oct · 6d ago

(opens in new tab)

CreditAccess Grameen Q2 Results: Profit jumps 4-fold as credit costs fall 43%; FY27 guidance raised

NewsCnbc-Tv18·22 Oct · 6d ago

(opens in new tab)

CreditAccess Grameen Q2 profit jumps fourfold to Rs 502 crore

NewsEt-Markets·22 Oct · 6d ago

(opens in new tab)
Neutral / worth noting (2)

CREDITACCESS GRAMEEN LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·22 Oct · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on CREDITACCESS GRAMEEN

All analyst calls on CREDITACCESS GRAMEEN

More from Emkay Global

Every call and its outcome